James Paul Scopa
CIK 1356950 · last filed 2025-12-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$966.7K
Companies
6
Total Filings
46
Lifetime Open-Market Net
$1.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 3,334 | $4.36 | $14.5K | $297.7K | 15 | 2025-12-10 |
| ALGS | Director | 183,083 | $5.28 | $966.7K | $0 | 7 | 2025-06-26 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | -$188.5K | 8 | 2023-08-09 |
| Histogen Inc. (CNAT) Delisted | Director | 1,010,099 | — | — | $1.82M | 5 | 2018-06-25 |
| TriVascular Technologies, Inc. (TRIV) Delisted | Director | 0 | — | — | $0 | 2 | 2016-02-04 |
| MEMY | 10%+ Owner | 0 | $22.23 | $0 | $0 | 1 | 2009-01-05 |
Recent Filings · Page 3 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-16 | DICE Therapeutics, Inc. (DICE) Delisted | Mixed | +6,000 | $102.0K | EDGAR |
| 2021-05-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-27 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-05 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Exer (M) | +23,334 | $151.2K | EDGAR |
| 2020-02-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +10,000 | $137.5K | EDGAR |
| 2019-08-16 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-02 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-06 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +20,000 | $134.2K | EDGAR |
| 2019-05-03 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.